Datwyler, a leading provider of high-quality, system-critical elastomer components, announces the launch of UltraShield™ at Interphex and CPhI North America, on April 25, 2023 – April 27, 2023. As a strategic partner and leader in the pharma packaging industry, Datwyler has developed its own film coating technology, becoming the first and sole supplier capable of offering both film and spray fluoropolymer coating technologies for elastomeric closures for injectable drugs. This extended range of coating options is designed to meet the highest demands for quality and performance for large and sensitive molecule drugs, allowing Datwyler to respond even better to specific applications and customer preferences.
“We want to become the most valued partner for parenteral packaging to the pharmaceutical industry by offering best-in-class products with a strong presence in new drug developments while leveraging our FirstLine® production standard and state-of-the-art global footprint,” said Dirk Borghs, CEO Datwyler Healthcare Solutions.
The proven concept of a fluoropolymer film coating technology in combination with Datwyler’s ultra-low extractable rubber formulation forms a protective barrier reducing drug-stopper interaction to obtain the lowest level of extractables. The chemical and functional characteristics of UltraShield have been specifically designed to securely store drugs under ultra-low temperatures up to -80°C and to provide compatibility with modern solvent-based drug excipients. The lubrication of the non-drug contact part of the stopper is fixed with an innovative curing system not requiring any additional curing agents. This results in flawless machineability while offering best-in-class subvisible particle levels and optimal chemical performance.
UltraShield™ is manufactured according to Datwyler’s FirstLine® concept ensuring the highest quality standards on the market. This standard is an advanced manufacturing concept for high-quality elastomer components for the healthcare industry with state-of-the-art clean room technology, automatic production cells, fully automatic camera inspection and a unique washing process.
UltraShield™ is the complementary solution to Datwyler’s existing product range. “With best-in-class extractable and leachable profiles and the highest quality standards, both UltraShield™ and OmniFlex® have a unique set of value-added features that makes them complementary in addressing any of our customers’ needs with the ultimate solution,” said Geert Moens, Global Platform Leader, Vial Closure Systems.
Datwyler – leading provider of high-quality, system-critical elastomer components
In billions of syringes and in every second car around the world, Datwyler components make an important contribution to patient and driver safety. The high-tech company focuses on high-quality, system-critical elastomer components and holds leading positions in attractive global markets such as healthcare, mobility, connectivity, general industry, and food & beverage. Datwyler materializes ideas for a safer, smarter and more sustainable world. Thanks to recognized core competencies, the company offers added value to its customers as a development partner. Its strategic priorities of profitable growth, sustainability, agility and digitalization make Datwyler an attractive partner for all stakeholders. With more than 25 production sites on four continents, sales in over 100 countries and more than 8’000 employees, the company generates annual revenue of more than CHF 1’100 million. Headquartered in Switzerland, Datwyler has been listed on the SIX Swiss Exchange since 1986 (security number 3048677).
Dätwyler Holding AG
Gotthardstr. 31
CH6460 Altdorf
Telefon: +41 (41) 8751304
Telefax: +41 (41) 8751205
http://www.daetwyler.ch
Head Corporate Communications
Telefon: +41 (41) 87519-00
Fax: +41 (41) 87512-05
E-Mail: guido.unternaehrer@daetwyler.ch
